Can you provide the last earnings date for VAXCYTE INC?
VAXCYTE INC (PCVX) last reported earnings on 2/24/2026.
NASDAQ:PCVX • US92243G1085
Past quarterly earnings results for VAXCYTE INC (PCVX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -1.80 | -1.55 | -16.44% | -77.51% | - | - | ||
| Q3 2025 | -1.56 | -1.29 | -20.53% | -87.95% | - | - | ||
| Q2 2025 | -1.22 | -1.19 | -2.10% | -10.91% | - | - | ||
| Q1 2025 | -1.04 | -1.07 | 2.74% | -22.35% | - | - | ||
| Q4 2024 | -1.01 | -1.16 | 12.92% | 44.29% | - | - | ||
| Q3 2024 | -0.83 | -1.16 | 28.30% | 8.79% | - | - | ||
| Q2 2024 | -1.10 | -1.00 | -9.49% | -57.14% | - | - | ||
| Q1 2024 | -0.85 | -1.19 | 28.70% | -21.43% | - | - | ||
| Q4 2023 | -1.82 | -1.09 | -66.45% | -78.43% | - | - | ||
| Q3 2023 | -0.91 | -0.85 | -6.53% | 2.15% | - | - | ||
| Q2 2023 | -0.70 | -0.76 | 7.88% | 12.50% | - | - | ||
| Q1 2023 | -0.70 | -0.84 | 16.89% | -2.94% | - | - | ||
| Q4 2022 | -1.02 | -0.95 | -7.53% | -85.45% | - | - | ||
| Q3 2022 | -0.93 | -0.85 | -8.98% | -82.35% | - | - | ||
| Q2 2022 | -0.80 | -0.70 | -13.67% | -73.91% | - | - | ||
| Q1 2022 | -0.68 | -0.64 | -6.38% | -65.85% | - | - | ||
| Q4 2021 | -0.55 | -0.57 | 3.71% | -34.15% | - | - | ||
| Q3 2021 | -0.51 | -0.56 | 8.54% | -24.39% | - | - | ||
| Q2 2021 | -0.46 | -0.53 | 13.82% | 73.26% | - | - | ||
| Q1 2021 | -0.41 | -0.49 | 17.12% | - | - | - | ||
| Q4 2020 | -0.41 | -0.55 | 25.56% | - | - | - | ||
| Q3 2020 | -0.41 | -0.45 | 9.33% | - | - | - | ||
| Q2 2020 | -1.72 | -1.29 | -33.13% | - | 255K | -100.00% | - | |
| Q1 2020 | - | - | - | - |
Notes
VAXCYTE INC (PCVX) last reported earnings on 2/24/2026.
VAXCYTE INC (PCVX) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, VAXCYTE INC (PCVX) has beaten EPS estimates in 1 out of 4 releases.